We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
Information for patients, healthcare professionals and developers of new medicines
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Practical steps to manage the risk of online harm if your online platform allows people to live stream, or view live streams by others.
Information on the potential health impacts of drought in England and the measures that people can take to stay healthy during these events.
Check what you need to do to sell cosmetic products in Great Britain.
Organisational definitions of terms concerned with risk and risk-related matters.
Information on how to report a serious undesirable effect (SUE) or safeguarding issue for cosmetic products.
How wind farms and wave and tidal energy devices can endanger navigation, emergency response operations, marine radar and GPS communications.
Advice on writing clear notices and maximising replies to your FSNs.
Information for public health professionals on immunisation.
Evidence-based recommendations to protect first responders from exposure to fentanyl.
Advice for parents and carers about the main risks children may be particularly vulnerable to and information about available help and support.
Healthcare professionals prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) are reminded to be alert to the risk of disabling and potentially long-lasting or irreversible side effects. Do not prescribe fluoroquinolones for non-severe or self-limiting infections, or for mild to...
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
The eighth annual #MedSafetyWeek social media campaign will take place from 6 to 12 November 2023. It will focus on the importance of reporting suspected adverse reactions to medicines and suspected problems with medical devices. We ask healthcare professionals to...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.